Balakumar Chandrasekaran
Zarqa University, Philadelphia University
Research areas: Chemistry · Organic Chemistry · Synthesis and biological activity · Synthesis and Characterization of Heterocyclic Compounds · Computational Drug Discovery Methods
0000-0003-4198-8679
About
Dr. Balakumar Chandrasekaran graduated with a Bachelor of Pharmacy Degree with First class from the prestigious University-The Tamilnadu Dr MGR Medical University, India (1998-2002). After qualifying the National Level Exam GATE-2003 with 95.32 percentile, he did Master of Pharmacy from LM College of Pharmacy, Gujarat University, India. He has received All India Council for Technical Education-AICTE fellowship and graduated his Master’s with Distinction Grade (2003-2005). After working as a lecturer in two different pharmacy colleges (2005-2007), he joined and conferred PhD from University Institute of Pharmaceutical Sciences (UIPS), Panjab University, India (Number-3 position for Pharma Institute in the Indian NIRF Ranking-2022) with prestigious national level competitive Research Fellowship in Science for Meritorious Students (RFSMS) by University Grants Commission (UGC), New Delhi, India (2007-2011).
After his PhD, he joined as an Assistant Professor at Karpagam College of Pharmacy, Coimbatore-India and was promoted to Associate Professor and Head of the Department of Pharmaceutical Medicinal Chemistry (2011-2015). During that period, he has supervised 5 M. Pharm research projects and secured several scientific research publications. He made significant contributions to the Karpagam institutions by serving in different capacities as Dean-in-charge at Karpagam University for the facilitation of PhD projects, Member of the Institutional Human Ethical Committee of Karpagam Medical College and Hospitals, and involved in establishing the pharma industry-Karpagam Pharma LLP, Coimbatore, India, which is presently running over 150 different formulations.
In the year 2015, he joined as a PostDoctoral Researcher to conduct research in the design and discovery of new anticancer drugs with the fellowship from School of Pharmacy, College of Health Sciences, University of KwaZulu-Natal (UKZN), South Africa. In the year 2016, he received the internationally competitive Prestigious Fellowship from the Department of Science and Technology (DST)-National Research Foundation (NRF), South Africa, to continue the anticancer drugs research foran additional two years at UKZN. During his tenure, Dr. Balakumar has supervised Master’s and PhD research students and established various international collaborations with countries such as USA, UK, France, Germany, Czech Republic, IICT-India and Saudi Arabia, and consequently published several research papers in high-impact-factor journals (2015-2017). In the year 2018, he joined the Faculty of Pharmacy, Philadelphia University-Jordan, and served for about 3 years (2018-2020). During the COVID-19 pandemic, he has shifted to India and worked as a Professor and Head of Department at SVCOPS, Tamilnadu, India, for a period of 1 year (2020-2021). Dr. Balakumar also worked as a Professor and Dean-School of Pharmacy-ITM University, Gwalior-India (2021-2022), and worked as a Professor at the Faculty of- Pharmacy, Philadelphia University-Jordan (2022-2025). Currently, he is working as a Professor at the Department of Pharmaceutical Science, Faculty of Pharmacy, Zarqa University-Jordan.
His area of specialization is Pharmaceutical Chemistry, Drug Design and Medicinal Chemistry and his research work includes computer-aided drug design, synthesis, characterization, and evaluation of nanoparticles, active pharmaceutical ingredients (APIs), pharmaceutical analysis of bulk drugs, Drug intermediates, impurities detection and quantification, synthesis of novel small organic molecules used as anticancer, antitubercular, anti-inflammatory, antimicrobial, anti-COVID and anti-asthmatic agents. He has published more than 80 papers, authored 24 book chapters, edited 3 books (2-Wiley; 1-Elsevier), and 3 Journals as a Guest Editor. He holds 09 international patents (India, South Africa, Australia, and PCT) to his credit. He is one of the editorial and review members for Elsevier, MDPI, Springer, and Frontiers Publishers. He is a notable associate editor in the following journals, having an impact factor of 5 and above: Frontiers in Molecular Biosciences, Frontiers in Pharmacology, and Frontiers in Oncology. He has presented the research work in 25 different scientific conferences, seminars, and workshops. He is the recipient of several research grants, including international research projects with the following universities: King Khalid University-KSA, Najran University-KSA, BIRAC-India, ITM University-India and De Montfort University, Leicester. His current research focuses on the implications of AI in disease prediction and decision-making towards the discovery of new drugs
Employment
-
Zarqa University Professor2025 - Present
-
Philadelphia University Professor2022 - 2025
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (100)
- Development of triazine-piperazine hybrids as a novel class of anticancer agents: Synthesis, biological evaluation, and in silico insights Save
- Systems Biology and Structure-Based In Silico Evaluations of Quercetin–Psychobiotic Interactions for the Management of Depression Save
- Additive Effects of Quercetin-Rich Allium cepa L. Juice and Dapagliflozin on Glycemic Variability in Streptozotocin-Induced Diabetic Rats Save
- Computational Molecular Docking and Molecular Dynamics Simulations of Potential Inhibitors from Cistus incanus (Cistaceae) Against Ebola Virus Save
- Recent medicinal chemistry efforts of targeting protein kinases for treating neurological conditions of Parkinson's and Alzheimer's diseases Save
- Exploring Phyto-Resources of Tulsi for the Management of Depression: A Discovery Through Computational and Pharmacological Studies Save
- Nanostructured Lipid Carriers (NLC)-Based Topical Formulation of Hesperidin for Effective Treatment of Psoriasis Save
- Computational Network Pharmacology, Molecular Docking, and Molecular Dynamics to Decipher Natural Compounds of Alchornea laxiflora for Liver Cancer Chemotherapy Save
- Microwave-Assisted Synthesis of Morpholine-Based Chalcones as Reversible MAO-A Inhibitors in the Management of Mental Depression Save
- Evaluation of anticancer activity of some new hybrids of 1,3,4-oxadiazole tethered cinnamamides Save
- Synthesis, Anticancer Screening, and In Silico Evaluations of Thieno[2,3-c]pyridine Derivatives as Hsp90 Inhibitors Save
- Emergent Natural Antioxidant Therapeutics to Cope with Oxidative Stress in Alzheimer’s Disease Save
- Insights into in silico analysis to explore the multitarget antidepressant role of Camellia sinensis Save
- Microwave-assisted Green Synthesis: An Approach for the Development of Anti-tubercular Agents Save
- Potential biomarkers in early detection of gastric cancer Save
- Pyridazinone: A privileged scaffold for synthetic and biomedical applications Save
- A QbD-Navigated Approach to the Development and Evaluation of Etodolac–Phospholipid Complex Containing Polymeric Films for Improved Anti-Inflammatory Effect Save
- A comprehensive overview of selective and novel fibroblast growth factor receptor inhibitors as a potential anticancer modality Save
- Benchmarking docking, density functional theory and molecular dynamics studies to assess the aldose reductase inhibitory potential of Trigonella foenum-graecum compounds for managing diabetes-associated complications Save
- Computational Design of a Novel Inhibitor against COVID Save